Transfusion management in the era of magrolimab (Hu5F9‐G4), an anti‐CD47 monoclonal antibody therapy

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 63; no. 12; pp. 2377 - 2383
Main Authors Singh, Nirupama, Staves, Julie, Storry, Jill R., Dinoso, Jason, Renard, Camille, Doshi, Parul, Johnson, Lisa D.S., Westhoff, Connie M., Murphy, Michael F.
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.12.2023
Wiley Subscription Services, Inc
Subjects
ABO typing interference
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
anti‐CD47
Blood Transfusion
CD47 Antigen
Clinical Medicine
Hematologi
Hematology
Hu5F9‐G4
Humans
Immunotherapy
Klinisk medicin
magrolimab
Medical and Health Sciences
Medicin och hälsovetenskap
Monoclonal antibodies
pretransfusion testing interference
serological interference
transfusion interference
ABO typing interference
anti-CD47
pretransfusion testing interference
serological interference
transfusion interference
Hu5F9-G4
magrolimab
Online AccessGet full text

Cover

More Information
Bibliography:Connie M. Westhoff and Michael F. Murphy are senior authors.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0041-1132
1537-2995
1537-2995
DOI:10.1111/trf.17597